|
"lin chia chi"的相關文件
顯示項目 11-20 / 148 (共15頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-04-15T03:58:41Z |
Immunotherapy in anaplastic thyroid cancer: Case series
|
Shih, Shyang-Rong; Chen, Kuan-Hua; Lin, Kuan-Yu; Yang, Pan-Chyr; KUEN-YUAN CHEN; Wang, Chun-Wei; Chen, Chun-Nan; Lin, Chih-Feng; Lin, Chia-Chi |
| 臺大學術典藏 |
2022-03-29 |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens
|
Yang, James Chih-Hsin; Chang, Chin-Hao; Chang, Yih-Leong; Huang, Yen-Lin; Chen, Jin-Shing; Lee, Jang-Ming; Feng-Ming Hsu; Lin, Chia-Chi; MA, WEI-LI |
| 臺大學術典藏 |
2022-03-23T08:16:48Z |
Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer
|
CHIANG, YUN; Wang, Chung-Chieh; Yu-Chieh Tsai; Huang, Chao-Yuan; Pu, Yeong-Shiau; Lin, Chia-Chi; Cheng, Jason Chia-Hsien |
| 臺大學術典藏 |
2022-02-21T06:00:15Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo, Jhe-Cyuan; Lin, Chen-Yuan; Lin, Chia-Chi; Huang, Ta-Chen; Lien, Ming-Yu; Lu, Li-Chun; HUNG-YANG KUO; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-11-29T06:37:51Z |
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLC
|
Zhu, Viola W; YEN-TING LIN; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; Lin, Chia-Chi; Soo, Ross A |
| 臺大學術典藏 |
2021-11-29T05:59:19Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
CHING-YAO YANG; Liao, Wei-Yu; Ho, Chao-Chi; Chen, Kuan-Yu; Tsai, Tzu-Hsiu; Hsu, Chia-Lin; Liu, Yi-Nan; Su, Kang-Yi; Chang, Yih-Leong; Wu, Chen-Tu; Liao, Bin-Chi; Hsu, Chia-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-11-29T05:57:16Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; CHING-YAO YANG; Tsai, Tzu-Hsiu; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T05:27:58Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; TZU-HSIU TSAI; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T03:22:49Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; WEI-YU LIAO; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-17T06:28:35Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; Liao, Wei-Yu; CHAO-CHI HO; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
顯示項目 11-20 / 148 (共15頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
